+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Critical Limb Ischemia Treatment Market - Global Forecast 2025-2030- Product Image
Critical Limb Ischemia Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Critical Limb Ischemia Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967998
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Critical Limb Ischemia Treatment Market is evolving rapidly as healthcare systems and industry stakeholders prioritize innovative therapies and strategic partnerships to address both clinical challenges and operational complexities. Emerging technologies and policy reforms are shaping a dynamic environment where proactive adaptation is increasingly essential for sustained leadership.

Market Snapshot: Critical Limb Ischemia Treatment Market

The Critical Limb Ischemia Treatment Market expanded from USD 4.46 billion in 2024 to USD 4.87 billion in 2025. With a compound annual growth rate of 8.94%, the market is projected to reach USD 7.45 billion by 2030. Key drivers include the rising incidence of peripheral arterial disease, demographic shifts leading to increased rates of diabetes and renal conditions, and ongoing investments in advanced therapies and healthcare infrastructure.

Scope & Segmentation of Critical Limb Ischemia Treatment

  • Treatment Modalities: Includes endovascular procedures such as angioplasty (with drug-coated and plain balloon options), atherectomy (directional, laser, orbital, and rotational), stenting (bare metal, drug-eluting), pharmacotherapy (antiplatelet agents, thrombolytics, vasodilators), supportive care (hyperbaric oxygen therapy, pain management, wound care), and surgical procedures (bypass surgery with autologous vein or synthetic grafts, endarterectomy).
  • Device Types: Comprises atherectomy devices, balloon technologies, embolic protection devices (distal filters, proximal occlusion balloons), stents (bare metal, covered, drug-eluting), and vascular grafts (autologous vein, synthetic).
  • End Users: Encompasses ambulatory surgery centers (both hospital owned and standalone), hospitals (private and public), and specialty vascular centers (hospital affiliated and independent).
  • Distribution Channels: Covers direct sales, hospital pharmacies (inpatient and outpatient), third-party distributors (retail pharmacies and wholesale distributors).
  • Regional Coverage: Analyses key markets across the Americas (including United States, Canada, Mexico, Brazil, and others), Europe, Middle East & Africa (with a broad country breakdown such as United Kingdom, Germany, France, Saudi Arabia, South Africa, and more), and Asia-Pacific (including China, India, Japan, Australia, among others).
  • Company Developments: Reviews trend impacts and innovations from leading players such as Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, LimFlow SA, Terumo Corporation, Cynata Therapeutics Ltd, Becton, Dickinson and Company, and Penumbra, Inc.

Key Takeaways for Senior Decision-Makers

  • Technological advancements, especially in imaging and precision delivery, are increasing the effectiveness and range of minimally invasive endovascular options.
  • Policy reforms are streamlining approval and reimbursement processes, encouraging the adoption of outcome-based models and supporting devices that demonstrate both safety and long-term benefits.
  • Stakeholder collaboration, including strategic partnerships between device manufacturers, pharmaceutical companies, and care facilities, is driving integrated therapeutic platforms and expanding access across regions.
  • Real-world evidence and post-market surveillance are becoming critical for demonstrating long-term value and influencing clinical guidelines and payer confidence.
  • Regional priorities and regulatory frameworks are impacting adoption rates and influencing the strategic positioning of companies in key growth markets.

Tariff Impact on Supply Chains

Recent tariff adjustments in the United States are creating significant cost pressures on imported atherectomy systems and drug-coated balloons. Providers and manufacturers are responding by diversifying supplier networks, pursuing near-shoring, and exploring domestically sourced materials. These shifts demand agile procurement strategies and enhanced collaboration to maintain therapy continuity and product availability.

Methodology & Data Sources

This report’s insights derive from structured interviews with vascular surgeons, interventional radiologists, and procurement specialists, complemented by secondary research spanning medical publications, regulatory filings, clinical trial databases, and industry white papers. Quantitative modeling is extensively validated through proprietary databases and scenario analysis, with expert advisory review ensuring practical relevance and analytical rigor.

Why This Report Matters to Decision-Makers

  • Gain actionable intelligence to refine product portfolios and supply chain strategies in response to shifting market and regulatory dynamics.
  • Support value-based decision-making by leveraging integrated data on technologies, clinical effectiveness, and evolving reimbursement models across global markets.

Conclusion

Accelerating innovation and cross-sector collaboration will define success in the Critical Limb Ischemia Treatment Market. Informed, adaptive strategies are key to optimizing outcomes and sustaining competitive advantage in this evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Accelerating adoption of autologous stem cell therapies for chronic critical limb ischemia treatment due to regenerative potential
5.2. Impact of evolving reimbursement frameworks on accessibility of advanced endovascular devices in CLI patients
5.3. Integration of wearable perfusion monitors and telehealth platforms for real time limb ischemia management and patient adherence
5.4. Rising preference for drug eluting balloons in below the knee interventions to reduce restenosis rates in diabetic CLI cohorts
5.5. Expansion of atherectomy procedures combined with intravascular imaging modalities to optimize lesion preparation in infra popliteal arteries
5.6. Development of bioresorbable scaffolds for peripheral arterial disease offering temporary support and long term vascular healing in CLI
5.7. Growing emphasis on early point of care diagnostic screening tools to detect asymptomatic peripheral microvascular disease in high risk diabetic populations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Critical Limb Ischemia Treatment Market, by Treatment Modality
8.1. Introduction
8.2. Endovascular Procedures
8.2.1. Angioplasty
8.2.1.1. Drug Coated Balloon
8.2.1.2. Plain Old Balloon
8.2.2. Atherectomy
8.2.2.1. Directional Atherectomy
8.2.2.2. Laser Atherectomy
8.2.2.3. Orbital Atherectomy
8.2.2.4. Rotational Atherectomy
8.2.3. Stenting
8.2.3.1. Bare Metal Stent
8.2.3.2. Drug Eluting Stent
8.3. Pharmacotherapy
8.3.1. Antiplatelet Agents
8.3.2. Thrombolytics
8.3.3. Vasodilators
8.4. Supportive Care
8.4.1. Hyperbaric Oxygen Therapy
8.4.2. Pain Management
8.4.3. Wound Care
8.5. Surgical Procedures
8.5.1. Bypass Surgery
8.5.1.1. Autologous Vein Graft
8.5.1.2. Synthetic Graft
8.5.2. Endarterectomy
9. Critical Limb Ischemia Treatment Market, by Device Type
9.1. Introduction
9.2. Atherectomy Devices
9.2.1. Directional Atherectomy
9.2.2. Laser Atherectomy
9.2.3. Orbital Atherectomy
9.2.4. Rotational Atherectomy
9.3. Balloons
9.3.1. Drug Coated Balloon
9.3.2. Plain Old Balloon
9.4. Embolic Protection Devices
9.4.1. Distal Filter
9.4.2. Proximal Occlusion Balloon
9.5. Stents
9.5.1. Bare Metal Stent
9.5.2. Covered Stent
9.5.3. Drug Eluting Stent
9.6. Vascular Grafts
9.6.1. Autologous Vein Graft
9.6.2. Synthetic Graft
10. Critical Limb Ischemia Treatment Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.2.1. Hospital Owned Centers
10.2.2. Standalone Centers
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Specialty Vascular Centers
10.4.1. Hospital Owned Centers
10.4.2. Independent Centers
11. Critical Limb Ischemia Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Hospital Pharmacies
11.3.1. Inpatient
11.3.2. Outpatient
11.4. Third Party Distributors
11.4.1. Retail Pharmacies
11.4.2. Wholesale Distributors
12. Americas Critical Limb Ischemia Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Critical Limb Ischemia Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Critical Limb Ischemia Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Boston Scientific Corporation
15.3.2. Medtronic plc
15.3.3. Abbott Laboratories
15.3.4. LimFlow SA
15.3.5. Terumo Corporation
15.3.6. Cynata Therapeutics Ltd
15.3.7. Becton, Dickinson and Company
15.3.8. Penumbra, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CRITICAL LIMB ISCHEMIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CRITICAL LIMB ISCHEMIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CRITICAL LIMB ISCHEMIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CRITICAL LIMB ISCHEMIA TREATMENT MARKET: RESEARCHAI
FIGURE 24. CRITICAL LIMB ISCHEMIA TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. CRITICAL LIMB ISCHEMIA TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. CRITICAL LIMB ISCHEMIA TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CRITICAL LIMB ISCHEMIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG COATED BALLOON, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG COATED BALLOON, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PLAIN OLD BALLOON, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PLAIN OLD BALLOON, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY LASER ATHERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY LASER ATHERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ORBITAL ATHERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ORBITAL ATHERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BARE METAL STENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BARE METAL STENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG ELUTING STENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG ELUTING STENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANTIPLATELET AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANTIPLATELET AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THROMBOLYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THROMBOLYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASODILATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASODILATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HYPERBARIC OXYGEN THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HYPERBARIC OXYGEN THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY WOUND CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AUTOLOGOUS VEIN GRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AUTOLOGOUS VEIN GRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SYNTHETIC GRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SYNTHETIC GRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDARTERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDARTERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY LASER ATHERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY LASER ATHERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ORBITAL ATHERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ORBITAL ATHERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG COATED BALLOON, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG COATED BALLOON, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PLAIN OLD BALLOON, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PLAIN OLD BALLOON, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTAL FILTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTAL FILTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PROXIMAL OCCLUSION BALLOON, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PROXIMAL OCCLUSION BALLOON, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BARE METAL STENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BARE METAL STENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COVERED STENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COVERED STENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG ELUTING STENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DRUG ELUTING STENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AUTOLOGOUS VEIN GRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AUTOLOGOUS VEIN GRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SYNTHETIC GRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SYNTHETIC GRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTS, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SPECIALTY VASCULAR CENTERS, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 262. UNITED STATES CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 263. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 264. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 265. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, 2018-2024 (USD MILLION)
TABLE 266. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ENDOVASCULAR PROCEDURES, 2025-2030 (USD MILLION)
TABLE 267. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, 2018-2024 (USD MILLION)
TABLE 268. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ANGIOPLASTY, 2025-2030 (USD MILLION)
TABLE 269. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 270. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 271. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, 2018-2024 (USD MILLION)
TABLE 272. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY STENTING, 2025-2030 (USD MILLION)
TABLE 273. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2024 (USD MILLION)
TABLE 274. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2025-2030 (USD MILLION)
TABLE 275. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2018-2024 (USD MILLION)
TABLE 276. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SUPPORTIVE CARE, 2025-2030 (USD MILLION)
TABLE 277. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2024 (USD MILLION)
TABLE 278. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2025-2030 (USD MILLION)
TABLE 279. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, 2018-2024 (USD MILLION)
TABLE 280. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BYPASS SURGERY, 2025-2030 (USD MILLION)
TABLE 281. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 282. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 283. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2024 (USD MILLION)
TABLE 284. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY ATHERECTOMY DEVICES, 2025-2030 (USD MILLION)
TABLE 285. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, 2018-2024 (USD MILLION)
TABLE 286. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY BALLOONS, 2025-2030 (USD MILLION)
TABLE 287. CANADA CRITICAL LIMB ISCHEMIA TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-202

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Critical Limb Ischemia Treatment market report include:
  • Boston Scientific Corporation
  • Medtronic plc
  • Abbott Laboratories
  • LimFlow SA
  • Terumo Corporation
  • Cynata Therapeutics Ltd
  • Becton, Dickinson and Company
  • Penumbra, Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.87 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.45 Billion
Compound Annual Growth Rate8.9%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Critical Limb Ischemia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033 - Product Image

Critical Limb Ischemia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033

  • Report
  • 194 Pages
  • Global
From
Critical Limb Ischemia Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F - Product Image

Critical Limb Ischemia Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Critical Limb Ischemia Treatment - Global Strategic Business Report - Product Image

Critical Limb Ischemia Treatment - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Critical Limb Ischemia Market Report 2025 - Product Image

Critical Limb Ischemia Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Critical Limb Ischemia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035 - Product Image

Critical Limb Ischemia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035

  • Report
  • 100 Pages
  • Global
From

About the Critical Limb Ischemia Drug Market

Critical Limb Ischemia (CLI) is a severe form of peripheral artery disease (PAD) that affects the lower extremities. It is caused by a narrowing of the arteries that supply blood to the legs, leading to a lack of oxygen and nutrients to the affected area. CLI can lead to severe pain, ulcers, and even amputation. The CLI drug market is a subset of the larger cardiovascular drug market. It is composed of drugs that are used to treat CLI, such as anticoagulants, antiplatelet agents, and vasodilators. These drugs are used to reduce the risk of further narrowing of the arteries, reduce pain, and improve blood flow to the affected area. The CLI drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, Sanofi, Bristol-Myers Squibb, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.